The Mass Spectrometry Revolution in Clinical Microbiology Part 1
Clinics in Laboratory Medicine, ISSN: 0272-2712, Vol: 45, Issue: 1, Page: 1-13
2025
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
The introduction of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has revolutionized infectious disease diagnostics over the past decade. In this review, we will first explore the history of how the once disparate fields of mass spectrometry (MS) and clinical microbiology inextricably merged. We will then review the rapid growth as well as current applications of MALDI-TOF MS in clinical microbiology. In the accompanying review, we will discuss some of the exciting and emerging applications of MS in pathogen detection, identification, and characterization.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S027227122400074X; http://dx.doi.org/10.1016/j.cll.2024.10.011; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85210754009&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/39892929; https://linkinghub.elsevier.com/retrieve/pii/S027227122400074X
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know